Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Temple, TX
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Tyler, TX
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Alexandria, VA
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated:  10/12/2017
mi
from
Antwerpen,
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated: 10/12/2017
mi
from
Antwerpen,
Click here to add this to my saved trials
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated:  10/12/2017
mi
from
Washington, D.C.,
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated: 10/12/2017
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
Status: Enrolling
Updated:  10/13/2017
Yale University
mi
from
New Haven, CT
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
Status: Enrolling
Updated: 10/13/2017
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Vorinostat in Treating Patients With Kidney Cancer
A Phase II, Pharmacokinetic and Biologic Correlative Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Renal Cell Carcinoma (RCC)
Status: Enrolling
Updated:  10/13/2017
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio
mi
from
San Antonio, TX
Vorinostat in Treating Patients With Kidney Cancer
A Phase II, Pharmacokinetic and Biologic Correlative Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Renal Cell Carcinoma (RCC)
Status: Enrolling
Updated: 10/13/2017
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Vorinostat in Treating Patients With Kidney Cancer
A Phase II, Pharmacokinetic and Biologic Correlative Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Renal Cell Carcinoma (RCC)
Status: Enrolling
Updated:  10/13/2017
The Institute for Drug Development
mi
from
San Antonio, TX
Vorinostat in Treating Patients With Kidney Cancer
A Phase II, Pharmacokinetic and Biologic Correlative Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Renal Cell Carcinoma (RCC)
Status: Enrolling
Updated: 10/13/2017
The Institute for Drug Development
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  10/16/2017
Anthony El-Khoueiry, Md
mi
from
Los Angeles, CA
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 10/16/2017
Anthony El-Khoueiry, Md
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  10/16/2017
Wayne State University
mi
from
Detroit, MI
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 10/16/2017
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  10/16/2017
University of Mississippi Medical Center
mi
from
Jackson, MS
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 10/16/2017
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  10/16/2017
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 10/16/2017
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  10/16/2017
Local Institution
mi
from
Parkville,
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 10/16/2017
Local Institution
mi
from
Parkville,
Click here to add this to my saved trials
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  10/16/2017
Winship Cancer Institute
mi
from
Atlanta, GA
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 10/16/2017
Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  10/16/2017
The Methodist Hospital Research Institute
mi
from
Houston, TX
Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 10/16/2017
The Methodist Hospital Research Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
A Phase 2 Study of Triapine® (NSC #663249) and Cisplatin in Combination With Pelvic Radiation for Treatment of Stage IB2-IVa Cervical Cancer or Stage II-IV Vaginal Cancer
Status: Enrolling
Updated:  10/16/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
A Phase 2 Study of Triapine® (NSC #663249) and Cisplatin in Combination With Pelvic Radiation for Treatment of Stage IB2-IVa Cervical Cancer or Stage II-IV Vaginal Cancer
Status: Enrolling
Updated: 10/16/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo(Registered Trademark) (Vincristine Sulfate Liposomes Injection) in Children and Adolescents With Refractory Cancer
Status: Enrolling
Updated:  10/16/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo(Registered Trademark) (Vincristine Sulfate Liposomes Injection) in Children and Adolescents With Refractory Cancer
Status: Enrolling
Updated: 10/16/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  10/16/2017
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 10/16/2017
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Arizona Center for Cancer Care - Peoria
mi
from
Peoria, AZ
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Arizona Center for Cancer Care - Peoria
mi
from
Peoria, AZ
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kaiser Permanente - Division of Research - Oakland
mi
from
Oakland, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kaiser Permanente - Division of Research - Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Rohnert Park Cancer Center
mi
from
Rohnert Park, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Rohnert Park Cancer Center
mi
from
Rohnert Park, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kaiser Permanente Medical Center - Roseville
mi
from
Roseville, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kaiser Permanente Medical Center - Roseville
mi
from
Roseville, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kaiser Permanente Santa Clara Medical Center
mi
from
Santa Clara, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kaiser Permanente Santa Clara Medical Center
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kaiser Permanente Medical Center - South San Francisco
mi
from
South San Francisco, CA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kaiser Permanente Medical Center - South San Francisco
mi
from
South San Francisco, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Urology Center of Colorado
mi
from
Denver, CO
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Urology Center of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Emory Crawford Long Hospital
mi
from
Atlanta, GA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Emory Crawford Long Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Queen's Cancer Institute at Queen's Medical Center
mi
from
Honolulu, HI
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Queen's Cancer Institute at Queen's Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Boston University Cancer Research Center
mi
from
Boston, MA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Boston University Cancer Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Oklahoma University Cancer Institute
mi
from
Oklahoma City, OK
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Oklahoma University Cancer Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Rosenfeld Cancer Center at Abington Memorial Hospital
mi
from
Abington, PA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Rosenfeld Cancer Center at Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Rothman Specialty Hospital
mi
from
Bensalem, PA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Rothman Specialty Hospital
mi
from
Bensalem, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Fox Chase Cancer Center Buckingham
mi
from
Furlong, PA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Fox Chase Cancer Center Buckingham
mi
from
Furlong, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Academic Urology Prostate Center
mi
from
King of Prussia, PA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Academic Urology Prostate Center
mi
from
King of Prussia, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
University of Virginia Cancer Center
mi
from
Charlottesville, VA
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
University of Virginia Cancer Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Columbia-Saint Mary's Cancer Care Center
mi
from
Milwaukee, WI
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Columbia-Saint Mary's Cancer Care Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
Saint Louis, MO
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated:  10/16/2017
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Radiation Therapy in Treating Patients With Prostate Cancer
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Status: Enrolling
Updated: 10/16/2017
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials